Northern Trust Corp Omeros Corp Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Omeros Corp stock. As of the latest transaction made, Northern Trust Corp holds 509,528 shares of OMER stock, worth $3.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
509,528
Previous 512,814 0.64%
Holding current value
$3.54 Million
Previous $2.08 Million 2.88%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$3.54 - $5.47 $11,632 - $17,974
-3,286 Reduced 0.64%
509,528 $2.02 Million
Q2 2024

Aug 14, 2024
SELL
$3.04 - $4.23 $125,533 - $174,673
-41,294 Reduced 7.45%
512,814 $2.08 Million
Q1 2024

May 14, 2024
SELL
$2.88 - $4.89 $14,238 - $24,176
-4,944 Reduced 0.88%
554,108 $1.91 Million
Q4 2023

Feb 13, 2024
BUY
$1.08 - $3.63 $14,049 - $47,222
13,009 Added 2.38%
559,052 $1.83 Million
Q3 2023

Nov 13, 2023
SELL
$2.81 - $5.69 $21,249 - $43,027
-7,562 Reduced 1.37%
546,043 $1.59 Million
Q2 2023

Aug 11, 2023
BUY
$4.45 - $7.57 $1.77 Million - $3.02 Million
398,321 Added 256.51%
553,605 $3.01 Million
Q1 2023

May 15, 2023
BUY
$2.48 - $5.22 $11,326 - $23,839
4,567 Added 3.03%
155,284 $722,000
Q4 2022

Feb 13, 2023
SELL
$1.75 - $3.96 $486 - $1,100
-278 Reduced 0.18%
150,717 $340,000
Q3 2022

Nov 14, 2022
BUY
$3.09 - $7.46 $5,438 - $13,129
1,760 Added 1.18%
150,995 $475,000
Q2 2022

Aug 12, 2022
SELL
$1.92 - $6.28 $957,987 - $3.13 Million
-498,952 Reduced 76.98%
149,235 $410,000
Q1 2022

May 13, 2022
SELL
$5.07 - $7.2 $119,464 - $169,653
-23,563 Reduced 3.51%
648,187 $3.9 Million
Q4 2021

Feb 08, 2022
SELL
$5.67 - $8.54 $113,394 - $170,791
-19,999 Reduced 2.89%
671,750 $4.32 Million
Q3 2021

Nov 15, 2021
SELL
$13.4 - $16.3 $27,161 - $33,040
-2,027 Reduced 0.29%
691,749 $9.54 Million
Q2 2021

Aug 13, 2021
BUY
$14.81 - $19.13 $59,091 - $76,328
3,990 Added 0.58%
693,776 $10.3 Million
Q1 2021

May 12, 2021
SELL
$14.52 - $23.53 $847,140 - $1.37 Million
-58,343 Reduced 7.8%
689,786 $12.3 Million
Q4 2020

Feb 11, 2021
SELL
$10.14 - $15.19 $174,681 - $261,678
-17,227 Reduced 2.25%
748,129 $10.7 Million
Q3 2020

Nov 16, 2020
BUY
$9.57 - $21.32 $351,965 - $784,106
36,778 Added 5.05%
765,356 $7.74 Million
Q2 2020

Aug 14, 2020
BUY
$12.21 - $16.99 $518,155 - $721,004
42,437 Added 6.18%
728,578 $10.7 Million
Q1 2020

May 14, 2020
BUY
$9.03 - $19.72 $349,596 - $763,459
38,715 Added 5.98%
686,141 $9.17 Million
Q4 2019

Feb 14, 2020
BUY
$13.01 - $17.15 $26,982 - $35,569
2,074 Added 0.32%
647,426 $9.12 Million
Q3 2019

Nov 13, 2019
BUY
$14.55 - $20.56 $133,016 - $187,959
9,142 Added 1.44%
645,352 $10.5 Million
Q2 2019

Aug 13, 2019
BUY
$15.0 - $19.62 $84,630 - $110,696
5,642 Added 0.89%
636,210 $9.98 Million
Q1 2019

May 13, 2019
BUY
$11.65 - $17.72 $156,051 - $237,359
13,395 Added 2.17%
630,568 $11 Million
Q4 2018

Feb 12, 2019
SELL
$10.72 - $16.73 $120,031 - $187,325
-11,197 Reduced 1.78%
617,173 $6.88 Million
Q3 2018

Nov 14, 2018
BUY
$17.73 - $26.69 $230,365 - $346,783
12,993 Added 2.11%
628,370 $15.3 Million
Q2 2018

Sep 18, 2018
SELL
$10.79 - $24.44 $34,053 - $77,132
-3,156 Reduced 0.51%
615,377 $11.2 Million
Q2 2018

Aug 14, 2018
BUY
$10.79 - $24.44 $172,456 - $390,624
15,983 Added 2.65%
618,533 $11.2 Million
Q1 2018

May 09, 2018
BUY
$9.0 - $20.16 $19,422 - $43,505
2,158 Added 0.36%
602,550 $6.73 Million
Q4 2017

Feb 14, 2018
SELL
$13.26 - $22.86 $1.05 Million - $1.82 Million
-79,413 Reduced 11.68%
600,392 $11.7 Million
Q3 2017

Nov 13, 2017
BUY
$19.76 - $24.9 $13.4 Million - $16.9 Million
679,805
679,805 $14.7 Million

Others Institutions Holding OMER

# of Institutions
120
Shares Held
25.6M
Call Options Held
228K
Put Options Held
630K
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $436M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email